Remix Therapeutics
Our Science
Platform
Pipeline
REM-422
About Us
Our Story
Our People
Our Investors
Our Partners
Join Us
News
News
Press Releases
Publications
Clinical Trials
Our Science
Platform
Pipeline
REM-422
About Us
Our Story
Our People
Our Investors
Our Partners
Join Us
News
News
Press Releases
Publications
Clinical Trials
Contact
Jan | 11 | 2021
News
First small-molecule drug targeting RNA gains momentum
By Cormac Sheridan, Nature Biotechnology
Read More
Back to News
Media Contact
media@remixtx.com
Investor Contact
WILL O’CONNOR
Precision AQ
Will.OConnor@precisionaq.com